NVS vs. ARA.TO

Last updated Jun 13, 2026

NVS (Novartis AG) and ARA.TO (Aclara Resources Inc.) are both stocks. NVS operates in Drug Manufacturers - General (Healthcare), while ARA.TO operates in Other Industrial Metals & Mining (Basic Materials). Over the past 3 years, NVS returned 19.57%/yr vs 107.42%/yr for ARA.TO. At a 0.03 correlation, their price movements are largely independent.

Performance

NVS vs. ARA.TO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Novartis AG (NVS) and Aclara Resources Inc. (ARA.TO). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

NVS is traded in USD, while ARA.TO is traded in CAD. To make them comparable, the ARA.TO values have been converted to USD using the latest available exchange rates.

Returns By Period

In the year-to-date period, NVS achieves a 14.40% return, which is significantly lower than ARA.TO's 98.99% return.

NVS

• 1D: -0.55%
• 1M: 2.22%
• YTD: 14.40%
• 6M: 18.98%
• 1Y: 30.60%
• 3Y*: 19.57%
• 5Y*: 14.77%
• 10Y*: 11.14%

ARA.TO

• 1D: 3.24%
• 1M: -12.44%
• YTD: 98.99%
• 6M: 97.43%
• 1Y: 361.20%
• 3Y*: 107.42%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

NVS vs. ARA.TO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
NVS Novartis AG	14.40%	46.95%	0.02%	16.14%	8.06%	8.74%
ARA.TO Aclara Resources Inc.	98.99%	402.96%	-17.03%	60.06%	-79.10%	-19.78%

Correlation

The correlation between NVS and ARA.TO is -0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.09
Correlation (3Y) Calculated over the trailing 3-year period	0.05
Correlation (All Time) Calculated using the full available price history since Dec 10, 2021	0.03

The correlation between NVS and ARA.TO shifts across timeframes, from -0.09 (1 year) to 0.05 (3 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap NVS : $293.28B ARA.TO : CA$968.23M
EPS NVS : $6.99 ARA.TO : -$0.05
PB Ratio NVS : 7.62 ARA.TO : 4.56
Total Revenue (TTM) NVS : $56.05B ARA.TO : $0.00
Gross Profit (TTM) NVS : $42.19B ARA.TO : -$1.03M
EBITDA (TTM) NVS : $22.40B ARA.TO : -$9.35M

Return for Risk

NVS vs. ARA.TO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NVS

NVS Risk / Return Rank: 80
NVS Sharpe Ratio Rank: 82
NVS Sortino Ratio Rank: 79
NVS Omega Ratio Rank: 77
NVS Calmar Ratio Rank: 80
NVS Martin Ratio Rank: 80

ARA.TO

ARA.TO Risk / Return Rank: 94
ARA.TO Sharpe Ratio Rank: 97
ARA.TO Sortino Ratio Rank: 93
ARA.TO Omega Ratio Rank: 90
ARA.TO Calmar Ratio Rank: 96
ARA.TO Martin Ratio Rank: 93

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NVS vs. ARA.TO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Novartis AG (NVS) and Aclara Resources Inc. (ARA.TO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	NVS	ARA.TO	Difference
Sharpe ratio: Return per unit of total volatility	1.47	3.26	-1.79
Sortino ratio: Return per unit of downside risk	2.10	3.37	-1.27
Omega ratio: Gain probability vs. loss probability	1.26	1.41	-0.15
Calmar ratio: Return relative to maximum drawdown	2.43	6.87	-4.44
Martin ratio: Return relative to average drawdown	5.88	14.21	-8.32

NVS vs. ARA.TO - Sharpe Ratio Comparison

The current NVS Sharpe Ratio is 1.47, which is lower than the ARA.TO Sharpe Ratio of 3.26. The chart below compares the historical Sharpe Ratios of NVS and ARA.TO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

NVS vs. ARA.TO - Drawdown Comparison

The maximum NVS drawdown since its inception was -42.10%, smaller than the maximum ARA.TO drawdown of -86.91%. Use the drawdown chart below to compare losses from any high point for NVS and ARA.TO.

Drawdown Indicators

	NVS	ARA.TO	Difference
Max Drawdown Largest peak-to-trough decline	-42.10%	-86.91%	+44.81%
Max Drawdown (1Y) Largest decline over 1 year	-12.65%	-52.99%	+40.34%
Max Drawdown (3Y) Largest decline over 3 years	-19.95%	-52.99%	+33.04%
Max Drawdown (5Y) Largest decline over 5 years	-20.42%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-26.03%	—	—
Current Drawdown Current decline from peak	-6.46%	-17.77%	+11.31%
Average Drawdown Average peak-to-trough decline	-10.92%	-61.47%	+50.55%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.23%	25.57%	-20.34%

Volatility

NVS vs. ARA.TO - Volatility Comparison

The current volatility for Novartis AG (NVS) is 7.18%, while Aclara Resources Inc. (ARA.TO) has a volatility of 22.54%. This indicates that NVS experiences smaller price fluctuations and is considered to be less risky than ARA.TO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NVS	ARA.TO	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.18%	22.54%	-15.36%
Volatility (6M) Calculated over the trailing 6-month period	14.96%	63.60%	-48.64%
Volatility (1Y) Calculated over the trailing 1-year period	21.02%	112.06%	-91.04%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	18.89%	91.57%	-72.68%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	19.64%	91.57%	-71.93%

Dividends

NVS vs. ARA.TO - Dividend Comparison

NVS's dividend yield for the trailing twelve months is around 3.12%, while ARA.TO has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ARA.TO Aclara Resources Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NVS Novartis AG	3.12%	2.90%	3.84%	3.44%	3.70%	3.86%	3.22%	3.03%	3.47%	3.24%	3.73%	3.10%

Financials

Frequently Asked Questions

Can I hold both NVS and ARA.TO in my portfolio?

NVS and ARA.TO have a correlation of -0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.